Literature DB >> 22999244

Diabetic cardiomyopathy: bench to bedside.

Joel D Schilling1, Douglas L Mann.   

Abstract

The study of diabetic cardiomyopathy is an area of significant interest given the strong association between diabetes and the risk of heart failure. Many unanswered questions remain regarding the clinical definition and pathogenesis of this metabolic cardiomyopathy. This article reviews the current understanding of diabetic cardiomyopathy with a particular emphasis on the unresolved issues that have limited translation of scientific discovery to patient bedside.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22999244      PMCID： PMC3457018          DOI： 10.1016/j.hfc.2012.06.007

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN： 1551-7136            Impact factor:   3.179


  119 in total

1.  PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.

Authors:  S O Marx; S Reiken; Y Hisamatsu; T Jayaraman; D Burkhoff; N Rosemblit; A R Marks
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

2.  Metformin therapy and prognosis of patients with heart failure and new-onset diabetes mellitus. A propensity-matched study in the community.

Authors:  Sotero P Romero; Jose L Andrey; Antonio Garcia-Egido; Miguel A Escobar; Virginia Perez; Ramón Corzo; Gloria J Garcia-Domiguez; Francisco Gomez
Journal:  Int J Cardiol       Date:  2011-11-21       Impact factor: 4.164

3.  Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha.

Authors:  P Wu; J M Peters; R A Harris
Journal:  Biochem Biophys Res Commun       Date:  2001-09-21       Impact factor: 3.575

4.  Clinical course of myocardial infarction among diabetic patients.

Authors:  A Czyzyk; A S Królewski; S Szabłowska; A Alot; J Kopczyński
Journal:  Diabetes Care       Date:  1980 Jul-Aug       Impact factor: 19.112

5.  Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway.

Authors:  Jennifer G Duncan; Juliet L Fong; Denis M Medeiros; Brian N Finck; Daniel P Kelly
Journal:  Circulation       Date:  2007-01-29       Impact factor: 29.690

6.  Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats.

Authors:  Anneleen Daniels; Dominik Linz; Marc van Bilsen; Hartmut Rütten; Thorsten Sadowski; Sven Ruf; Hans-Paul Juretschke; Claudia Neumann-Haefelin; Chantal Munts; Ger J van der Vusse; Frans A van Nieuwenhoven
Journal:  Eur J Heart Fail       Date:  2012-02       Impact factor: 15.534

7.  Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production.

Authors:  Gang Ye; Naira S Metreveli; Jun Ren; Paul N Epstein
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

8.  Prevalence and mortality of acute myocardial infarction in patients with diabetes.

Authors:  L Rytter; S Troelsen; H Beck-Nielsen
Journal:  Diabetes Care       Date:  1985 May-Jun       Impact factor: 19.112

9.  Collagen remodelling in myocardia of patients with diabetes.

Authors:  M Shimizu; K Umeda; N Sugihara; H Yoshio; H Ino; R Takeda; Y Okada; I Nakanishi
Journal:  J Clin Pathol       Date:  1993-01       Impact factor: 3.411

10.  Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus.

Authors:  David Aguilar; Anita Deswal; Kumudha Ramasubbu; Douglas L Mann; Biykem Bozkurt
Journal:  Am J Cardiol       Date:  2009-12-22       Impact factor: 2.778
View more
  46 in total

1.  Atorvastatin alleviates experimental diabetic cardiomyopathy by suppressing apoptosis and oxidative stress.

Authors:  Ahmed A M Abdel-Hamid; Alaa El-Din L Firgany
Journal:  J Mol Histol       Date:  2015-06-04       Impact factor: 2.611

2.  Retinol-Binding Protein 4 Induces Cardiomyocyte Hypertrophy by Activating TLR4/MyD88 Pathway.

Authors:  Wei Gao; Hao Wang; Lin Zhang; Yang Cao; Ji-Zhang Bao; Zheng-Xia Liu; Lian-Sheng Wang; Qin Yang; Xiang Lu
Journal:  Endocrinology       Date:  2016-04-21       Impact factor: 4.736

3.  Glycogen Synthase Kinase-3α Promotes Fatty Acid Uptake and Lipotoxic Cardiomyopathy.

Authors:  Michinari Nakamura; Tong Liu; Seema Husain; Peiyong Zhai; Junco S Warren; Chiao-Po Hsu; Takahisa Matsuda; Christopher J Phiel; James E Cox; Bin Tian; Hong Li; Junichi Sadoshima
Journal:  Cell Metab       Date:  2019-02-07       Impact factor: 27.287

Review 4.  Evidence for distinct effects of exercise in different cardiac hypertrophic disorders.

Authors:  Emily J Johnson; Brad P Dieter; Susan A Marsh
Journal:  Life Sci       Date:  2015-01-26       Impact factor: 5.037

5.  Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice.

Authors:  Brian Bostick; Javad Habibi; Vincent G DeMarco; Guanghong Jia; Timothy L Domeier; Michelle D Lambert; Annayya R Aroor; Ravi Nistala; Shawn B Bender; Mona Garro; Melvin R Hayden; Lixin Ma; Camila Manrique; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-06       Impact factor: 4.733

Review 6.  Role of cardiac MRI in diabetes.

Authors:  Ravi V Shah; Siddique A Abbasi; Raymond Y Kwong
Journal:  Curr Cardiol Rep       Date:  2014-02       Impact factor: 2.931

Review 7.  The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise.

Authors:  Joel D Schilling
Journal:  Antioxid Redox Signal       Date:  2015-04-15       Impact factor: 8.401

8.  Restoring redox balance enhances contractility in heart trabeculae from type 2 diabetic rats exposed to high glucose.

Authors:  Niraj M Bhatt; Miguel A Aon; Carlo G Tocchetti; Xiaoxu Shen; Swati Dey; Genaro Ramirez-Correa; Brian O'Rourke; Wei Dong Gao; Sonia Cortassa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

Review 9.  Metabolic dysfunction in diabetic cardiomyopathy.

Authors:  Michael Isfort; Sarah C W Stevens; Stephen Schaffer; Chian Ju Jong; Loren E Wold
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

10.  Youth with type 1 diabetes have worse strain and less pronounced sex differences in early echocardiographic markers of diabetic cardiomyopathy compared to their normoglycemic peers: A RESistance to InSulin in Type 1 ANd Type 2 diabetes (RESISTANT) Study.

Authors:  Petter Bjornstad; Uyen Truong; Laura Pyle; Jennifer L Dorosz; Melanie Cree-Green; Amy Baumgartner; Gregory Coe; Judith G Regensteiner; Jane E B Reusch; Kristen J Nadeau
Journal:  J Diabetes Complications       Date:  2016-04-13       Impact factor: 2.852
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.